Report on Webinar Series Cell and Gene Therapy: From Concept to Clinical Use
暂无分享,去创建一个
C. F. van der Walle | C. Dufès | Arpan S. Desai | Julie E Kerby | J. Broadhead | Alice Tam | Z. Rattray
[1] C. Dufès,et al. Regression of Melanoma Following Intravenous Injection of Plumbagin Entrapped in Transferrin-Conjugated, Lipid–Polymer Hybrid Nanoparticles , 2021, International journal of nanomedicine.
[2] T. Darwish,et al. Apolipoprotein E Binding Drives Structural and Compositional Rearrangement of mRNA-Containing Lipid Nanoparticles , 2021, ACS nano.
[3] H. Leung,et al. Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cells. , 2020, Biomaterials science.
[4] S. Boye,et al. Current Clinical Applications of In Vivo Gene Therapy with AAVs , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[5] S. Nierkens,et al. Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors , 2020, Vaccines.
[6] J. Gauthier,et al. Taming the beast: CRS and ICANS after CAR T-cell therapy for ALL , 2020, Bone Marrow Transplantation.
[7] J Fraser Wright,et al. Quality Control Testing, Characterization and Critical Quality Attributes of Adeno‐Associated Virus Vectors Used for Human Gene Therapy , 2020, Biotechnology journal.
[8] P. Alves,et al. Advances in Lentivirus Purification , 2020, Biotechnology journal.
[9] L. Rittié,et al. Short time to market and forward planning will enable cell therapies to deliver R&D pipeline value. , 2020, Human gene therapy.
[10] Michael L. Wang,et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study , 2020, The Lancet.
[11] Elizabeth L Siegler,et al. Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies , 2020, Frontiers in Immunology.
[12] C. Vink,et al. Rapid Lentiviral Vector Producer Cell Line Generation Using a Single DNA Construct , 2020, Molecular therapy. Methods & clinical development.
[13] W. Jiskoot,et al. Particulate impurities in cell-based medicinal products traced by flow imaging microscopy combined with deep learning for image analysis. , 2020, Cytotherapy.
[14] A. Bornot,et al. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles , 2020, SLAS discovery : advancing life sciences R & D.
[15] S. Rives,et al. Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial , 2020, Frontiers in Immunology.
[16] A. Jones,et al. Endocytic Profiling of Cancer Cell Models Reveals Critical Factors Influencing LNP-Mediated mRNA Delivery and Protein Expression. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[17] H. Leung,et al. Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells. , 2019, Nanoscale.
[18] S. Grupp,et al. ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells. , 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] Arpan S. Desai,et al. Using macropinocytosis for intracellular delivery of therapeutic nucleic acids to tumour cells , 2018, Philosophical Transactions of the Royal Society B.
[20] C. Dufès,et al. Targeted nonviral gene therapy in prostate cancer , 2018, International journal of nanomedicine.
[21] Elizabeth Csaszar,et al. Commercial Scale Manufacturing of Allogeneic Cell Therapy , 2018, Front. Med..
[22] B. Pickard,et al. PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells , 2018, Scientific Reports.
[23] C. Dufès,et al. Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[24] Guideline on the quality, non-clinical and clinical aspects of gene therapy medicinal products , 2015 .
[25] L. Couture,et al. Production of CGMP-Grade Lentiviral Vectors. , 2012, BioProcess international.
[26] Laurence Tetley,et al. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. , 2010, Journal of controlled release : official journal of the Controlled Release Society.